Giuseppe Masucci

12.0k total citations
125 papers, 4.8k citations indexed

About

Giuseppe Masucci is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Giuseppe Masucci has authored 125 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Immunology, 62 papers in Oncology and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Giuseppe Masucci's work include Immunotherapy and Immune Responses (49 papers), Immune Cell Function and Interaction (49 papers) and Cancer Immunotherapy and Biomarkers (35 papers). Giuseppe Masucci is often cited by papers focused on Immunotherapy and Immune Responses (49 papers), Immune Cell Function and Interaction (49 papers) and Cancer Immunotherapy and Biomarkers (35 papers). Giuseppe Masucci collaborates with scholars based in Sweden, United States and Germany. Giuseppe Masucci's co-authors include Rolf Kiessling, Johan Hansson, Isabel Poschke, Maria G. Masucci, Max Petersson, Eva Klein, Dimitrios Mougiakakos, Andreas Lundqvist, Flavio Salazar‐Onfray and Peter Ragnhammar and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Giuseppe Masucci

125 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Masucci Sweden	40	3.2k	2.5k	908	458	363	125	4.8k
Vincent Ling United States	28	4.9k 1.5×	3.6k 1.4×	1.4k 1.5×	338 0.7×	558 1.5×	49	7.6k
Pavel Pisa Sweden	42	2.6k 0.8×	2.1k 0.8×	1.5k 1.7×	391 0.9×	748 2.1×	103	5.6k
David Berd United States	39	2.2k 0.7×	2.2k 0.9×	1.6k 1.8×	363 0.8×	239 0.7×	118	4.4k
Pablo Sarobe Spain	39	2.6k 0.8×	2.0k 0.8×	1.5k 1.7×	382 0.8×	552 1.5×	125	5.5k
Alain Schweitzer Switzerland	22	2.9k 0.9×	1.5k 0.6×	1.1k 1.2×	298 0.7×	183 0.5×	36	5.0k
Mary Philip United States	22	3.0k 0.9×	2.7k 1.1×	1.2k 1.4×	164 0.4×	350 1.0×	64	4.9k
Emma Di Carlo Italy	45	4.0k 1.3×	2.9k 1.1×	1.8k 2.0×	715 1.6×	401 1.1×	125	6.1k
Laura Carter United States	23	5.2k 1.6×	4.1k 1.6×	1.1k 1.3×	247 0.5×	644 1.8×	45	7.7k
Thomas H. Tötterman Sweden	38	2.2k 0.7×	1.4k 0.6×	1.0k 1.1×	362 0.8×	233 0.6×	150	4.7k
Sebastian Kobold Germany	36	2.7k 0.8×	3.3k 1.3×	1.7k 1.9×	380 0.8×	353 1.0×	141	5.5k

Countries citing papers authored by Giuseppe Masucci

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Masucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Masucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Masucci more than expected).

Fields of papers citing papers by Giuseppe Masucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Masucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Masucci. The network helps show where Giuseppe Masucci may publish in the future.

Co-authorship network of co-authors of Giuseppe Masucci

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Masucci. A scholar is included among the top collaborators of Giuseppe Masucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Masucci. Giuseppe Masucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madonna, Gabriele, Giuseppe Masucci, Mariaelena Capone, et al.. (2021). Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy. Cancers. 13(16). 4164–4164. 7 indexed citations

Villabona, Lisa, Giuseppe Masucci, & Peter Ragnhammar. (2019). Gender differences in prognostic value of immune-related biomarkers in colon cancer patients randomized to surgery or surgery and adjuvant chemotherapy treatment.. Journal of Clinical Oncology. 37(15_suppl). 3603–3603. 1 indexed citations

Villabona, Lisa, D Rodríguez, Emilia Andersson, et al.. (2014). A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA. Modern Pathology. 27(9). 1296–1305. 4 indexed citations

Coaña, Yago Pico de, Isabel Poschke, Giusy Gentilcore, et al.. (2013). Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production. Cancer Immunology Research. 1(3). 158–162. 110 indexed citations

Mao, Yumeng, Isabel Poschke, Erik Wennerberg, et al.. (2013). Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms. Cancer Research. 73(13). 3877–3887. 157 indexed citations

Poschke, Isabel, Dimitrios Mougiakakos, Johan Hansson, Giuseppe Masucci, & Rolf Kiessling. (2010). Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign. Cancer Research. 70(11). 4335–4345. 329 indexed citations

Quaglino, Elena, Cristina Mastini, Augusto Amici, et al.. (2010). A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins. Cancer Research. 70(7). 2604–2612. 53 indexed citations

Zohar, Sarah, Ileana Baldi, Guido Forni, et al.. (2010). Planning a Bayesian early‐phase phase I/II study for human vaccines in HER2 carcinomas. Pharmaceutical Statistics. 10(3). 218–226. 10 indexed citations

Johansson, C. Christian, Suzanne Egyházi, Giuseppe Masucci, et al.. (2008). Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunology Immunotherapy. 58(7). 1085–1094. 41 indexed citations

10.

Norell, Håkan, Mattias Carlsten, Karl‐Johan Malmberg, et al.. (2006). Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity. Cancer Research. 66(12). 6387–6394. 52 indexed citations

11.

Masucci, Giuseppe, Eva Månsson‐Brahme, Boel Ragnarsson-Olding, et al.. (2006). Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma. Melanoma Research. 16(4). 357–363. 13 indexed citations

12.

Malmberg, Karl‐Johan, Velmurugesan Arulampalam, Fumiko Ichihara, et al.. (2001). Inhibition of Activated/Memory (CD45RO+) T Cells by Oxidative Stress Associated with Block of NF-κB Activation. The Journal of Immunology. 167(5). 2595–2601. 121 indexed citations

13.

Masucci, Giuseppe, Anna Svensson, Mona Hansson, et al.. (1997). Efficient Harvest of In Vivo IL-2-Activated CD3+ Lymphocytes for Adoptive Immunotherapy by Selective Leukapheresis (Lymphocytapheresis). Journal of Hematotherapy. 6(3). 253–260. 7 indexed citations

14.

Reali, Eva, H Mellstedt, & Giuseppe Masucci. (1993). GM-CSF augments the IL-4-induced cytotoxic activity of human mononuclear cells in the presence of the mouse monoclonal antibody 17-1A. 6(3). 116–122. 1 indexed citations

15.

Frödin, Jan‐Erik, Ann‐Kari Lefvert, Giuseppe Masucci, et al.. (1991). Induction of Anti-Idiotypic (ab ₂ ) and Anti-Anti-Idiotypic (ab ₃ ) Antibodies in Patients Treated with the Mouse Monoclonal Antibody 17-1A (ab ₁ ). Relation to the Clinical Outcome — An Important Antitumoral Effector Function?. Hybridoma. 10(4). 421–431. 37 indexed citations

16.

Wersäll, Peter, Giuseppe Masucci, & Håkan Mellstedt. (1991). Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunology Immunotherapy. 33(1). 45–49. 10 indexed citations

17.

Masucci, Giuseppe, Peter Ragnhammar, Peter Wersäll, & Håkan Mellstedt. (1990). Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A). Cancer Immunology Immunotherapy. 31(4). 231–235. 45 indexed citations

18.

Masucci, Giuseppe, et al.. (1989). Lymphokine Activated Killer (LAK) Cells in Antibody Dependent Cellular Cytotoxicity (ADCC) Using MAb 17-1A: A Combination of Potential Usefulness in Tumor Therapy. Hybridoma. 8(5). 507–516. 16 indexed citations

19.

Masucci, Giuseppe, et al.. (1988). Effect of Human Blood Mononuclear Cell Populations in Antibody Dependent Cellular Cytotoxicity (ADCC) Using Two Murine (CO 17-1A and Br55-2) and One Chimeric (17-1A) Monoclonal Antibodies Against a Human Colorectal Carcinoma Cell Line (SW948). Hybridoma. 7(5). 429–440. 22 indexed citations

20.

Zeuthen, Jesper, George Klein, Raphael Ber, et al.. (1982). Human Lymphoma-Lymphoma Hybrids and Lymphoma-Leukemia Hybrids. I. Isolation, Characterization, Cell Surface Markers, and B-Cell Markers<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 68(2). 179–95. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact